Article Information
vol. 8 no. 4
Published By
Online ISSN
History
- Received February 17, 2022
- Accepted September 4, 2022
- Published online November 28, 2022.
Article Versions
- previous version (October 27, 2022 - 06:16).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Shahid Siddiqui1,
- Claus Bachert2,3,4,
- Adam M. Chaker5,
- Joseph K. Han6,
- Peter W. Hellings2,7,
- Anju T. Peters8,
- Enrico Heffler9,10,
- Siddhesh Kamat1,
- Haixin Zhang1,
- Scott Nash1⇑,
- Asif H. Khan11,
- Lucia De Prado Gomez12,
- Juby A. Jacob-Nara13,
- Paul J. Rowe13 and
- Yamo Deniz1
- 1Medical Affairs, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
- 2Upper Airways Research Laboratory and Department of Otorhinolaryngology, Ghent University, Ghent, Belgium
- 3Division of ENT Diseases, CLINTEC, Karolinska Institutet, Stockholm, Sweden
- 4Sun Yat-sen University, The First Affiliated Hospital, Guangzhou, China
- 5TUM Medical School, Klinikum rechts der Isar, Department of Otolaryngology and ZAUM, Technical University of Munich, Munich, Germany
- 6Department of Otolaryngology and Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, VA, USA
- 7Department of Otorhinolaryngology – Head and Neck Surgery, University Hospitals Leuven, Leuven, Belgium
- 8Division of Allergy and Immunology and Sinus and Allergy Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
- 9Allergy and Respiratory Diseases, Humanitas Clinical and Research Center IRCCS, Milan, Italy
- 10Department of Biomedical Sciences, Humanitas University, Milan, Italy
- 11Global Medical Affairs, Sanofi, Chilly-Mazarin, France
- 12Global Medical Affairs, Sanofi, Reading, UK
- 13Global Medical Affairs, Sanofi, Bridgewater, NJ, USA
- Corresponding author: Scott Nash (scott.nash{at}regeneron.com)
Funding
Regeneron Pharmaceuticals, Inc.
Sanofi
Article usage
Altmetrics
Vol 8 Issue 4
Table of Contents
AROMA: real-world global registry of dupilumab for chronic rhinosinusitis with nasal polyps
